PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to fight Tough-to-Treat prostate cancer
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs could help control advanced prostate cancer that had stopped responding to standard hormone therapy. It involved 69 men whose cancer had specific genetic features that might make it more responsive to immunotherap…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Phase: PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Real-World data reveals which prostate cancer drug helps men live longer
Disease control CompletedThis study looked at real-world medical records to compare two common drugs for advanced prostate cancer: enzalutamide and abiraterone. Researchers analyzed data from over 2,700 men who had not yet received chemotherapy to see which treatment was associated with longer survival a…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC